TY  - JOUR
AU  - Mukama, Trasias
AU  - Fortner, Renée Turzanski
AU  - Katzke, Verena
AU  - Hynes, Lucas Cory
AU  - Petrera, Agnese
AU  - Hauck, Stefanie M
AU  - Johnson, Theron
AU  - Schulze, Matthias
AU  - Schiborn, Catarina
AU  - Rostgaard-Hansen, Agnetha Linn
AU  - Tjønneland, Anne
AU  - Overvad, Kim
AU  - Sanchez-Perez, Maria-Jose
AU  - Crous-Bou, Marta
AU  - Chirlaque, María-Dolores
AU  - Amiano, Pilar
AU  - Ardanaz, Eva
AU  - Watts, Eleanor L
AU  - Travis, Ruth C
AU  - Sacerdote, Carlotta
AU  - Grioni, Sara
AU  - Masala, Giovanna
AU  - Signoriello, Simona
AU  - Tumino, Rosario
AU  - Gram, Inger T
AU  - Sandanger, Torkjel M
AU  - Sartor, Hanna
AU  - Lundin, Eva
AU  - Idahl, Annika
AU  - Heath, Alicia K
AU  - Dossus, Laure
AU  - Weiderpass, Elisabete
AU  - Kaaks, Rudolf
AU  - https://www.nature.com/articles/s41416-021-01697-z
PY  - 2022
DO  - 10.1038/s41416-021-01697-z
UR  - http://hdl.handle.net/10668/19522
T2  - British journal of cancer
AB  - CA125 is the best available yet insufficiently sensitive biomarker for early detection of ovarian cancer. There is a need to identify novel biomarkers, which individually or in combination with CA125 can achieve adequate sensitivity and specificity...
LA  - en
PB  - Nature
KW  - ADAM Proteins
KW  - Biomarkers, Tumor
KW  - Blood Proteins
KW  - CA-125 Antigen
KW  - Carcinoma, Ovarian Epithelial
KW  - Case-Control Studies
KW  - Early Detection of Cancer
KW  - Female
KW  - Folate Receptor 1
KW  - Humans
KW  - Membrane Proteins
KW  - Ovarian Neoplasms
KW  - ROC Curve
TI  - Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer.
TY  - research article
VL  - 126
ER  -